The mutations identified in APC, GNAS, and BRAF were found in serous (1/64, 1.6%), endometrioid (1/5, 20.0%), and mucinous (1/1, 100.0%) tumor samples, respectively (Figure 2a,b,e). This evidence concerns the gene APC and neoplasm.